WS-7528, produced by Streptomyces sp. No. 7528, was extracted from cultured broth, purified by solvent extraction followed by chromatography on silica gel and then isolated as pale yellow powder (C16H14O5, mp 95~98°C). WS-7528 inhibited estrogen binding to its receptor protein in rat uterine cytosol. The IC50 value of WS-7528for partially purified rat uterine cytosol receptor was 5.7x 10"8m.
(Received for publication April 7, 1990) WS-7528, produced by Streptomyces sp. No. 7528, was extracted from cultured broth, purified by solvent extraction followed by chromatography on silica gel and then isolated as pale yellow powder (C16H14O5, mp 95~98°C). WS-7528 inhibited estrogen binding to its receptor protein in rat uterine cytosol. The IC50 value of WS-7528for partially purified rat uterine cytosol receptor was 5 .7x 10"8m.
This compound was found to induce the growth of the estrogen dependent cell line MCF-7. WS-7528 was tested orally and subcutaneously in immature rats to confirm its effect on the growth of the uterus. WS-7528has also weak anti-inflammatory activity on the carrageenin paw edemaof the rat model.
Osteoporosis is a disease which occures frequently in postmenopausal females. Estrogens like diethylstilbestrol have been used in clinical treatment of osteoporosis in Europe and the United States. 1>2) However, these estrogens are so potent that they are toxic to the mammaryglands, liver and cardiovascular system. Therefore, our aim has been to screen for nonsteroidal compounds which display milder estrogenic activities than conventional estrogens. We found a new estrogen-like substance, WS-7528, from the fermentation broth of a strain of Streptomyces. In this paper, we describe the taxonomy of the producing strain, the fermentation, the isolation, the physico-chemical properties and biological activities of WS-7528.
Materials and Methods

Taxonomic Studies
The strain No. 7528 was isolated from a soil sample obtained at Mt. Takami, Nara Prefecture, Japan. The methods described by Shirling and Gottlieb3) were employed for this taxonomic study. Morphological observations were made with light and electron microscopes from cultures grown at 30°C for 14 days on yeast extract-malt extract agar, oatmeal agar and inorganic salts -starch agar.
Cultural properties were observed on ten media described by Shiring and Gottlieb,3) and Waksman.4) Incubation was carried out at 30°C for 14 days. Color assignments were made using the MethuenHandbook of Colour. 5) Cell wall analysis was performed by the methods of Becker et al.6) and Yamaguchi.7) Temperature range for growth was determined on yeast extract -malt extract agar using a temperature gradient incubator TN-3 (Advantec Toxo Co., Ltd.). 1 395 Utilization of carbon sources was examined according to the methods of Pridham and Gottlieb.8) Fermentati on A loopful of a mature slant of Streptomyces sp. No. 7528 was inoculated to a seed medium (80ml) containing corn starch 1%, glycerol 1%, glucose 0.5%, Pharmamedia (cotton seed flour, trade mark, purchased from Iwaki Yakuhin) 1 %, corn steep liquor 0.5%, Molatin (dried yeast, trade mark, purchased from Kanegafuchi Chemical Ind. Co., Ltd.) 0.5% and calcium carbonate 0.2% (pH 6.5) in a 250-ml Erlenmeyer flask and cultured at 30°C for 72 hours on a rotary shaker with 7.5-cm throw at 200rpm.
Sixteen hundred ml of the seed culture were inoculated to the production mediumcontaining soluble starch 2%, Pharmamedia 0.5%, gluten meal 0.5%, Molatin 0.25%, and corn steep liquor 0.25% (pH 6.5) in a 200-liter jar fermenter and cultured at 30°C for 72 hours under aeration of 160 liters/minute and agitation of 300 rpm.
Structural Studies IR spectrum was recorded on a Jasco A-102 spectrophotometer. *H and 13C NMR spectra were measured on a Bruker AM400WB spectrometer. The chemical shifts are given in ppm (S) relative to internal TMS.UVspectra were measured on a Hitachi 220Aspectrophotometer. El mass spectra was recorded using a VGZAB-SEmass spectrometer. MPwas measured with a Yanagimotomicroscope hot-stage apparatus and is uncorrected. Preparative TLC (PTLC) was performed on pre-coated Silica gel 60 F254 plates (E. Merck).
Preparation of Estradiol Receptor in Uterine Cytosol
Mature Sprague-Dawley female rats (7 to 8 weeks old) were ovariectomized and 2 days later, rats were sacrificed.
The uteri were homogenized using buffer consisting ofglycerol 10%, monothioglycerol 0. 1 %, KH2PO4 5mM, pH 7.4 (1 g/4ml of buffer) with a Polytron in the cold room. The homogenate was centrifuged at 100,000 x g for 30 minutes in a Beckmanultracentrifuge.
The protein concentration in the cytosol was about 1 mg/ml. This cytosol solution was used as source of estradiol receptors. TBq/mmol, New England Nuclear, 14.8KBq/ml) and 200/il of the partially purified receptor. After incubation at 0°C for 90 minutes, bound estradiol was separated from unbound estradiol using dextran-coated charcoal by addition of 250 fil of solution containing 5 mg/ml Norit A (Nakarai Chemicals, Ltd.), 0.5 mg/ml Dextran T-70 (Pharmacia Fine Chemicals, Ltd.) and 8 mg/ml NaCl to the reaction mixture and incubating for 5 minutes. Then samples were centrifuged at 1,000 x g for 5 minutes to remove the charcoal.
Estrogen Receptor Binding Assay
The radioactivity in 50 fi\ of supernatant was counted in 5 ml of Aquazol-2 (New England Nuclear) with a Packard scintillation counter (Packard TRI-CARB4530). Specifically bound estradiol was determined as the amountof [3H]estradiol boundin the absence of the non-radioactive estradiol minus the amount of [3H]estradiol bound in the presence of 200-fold excess concentration of non-radioactive estradiol.
Soft Agar Colony Assay
The assay for colony growth in soft agar was performed in 24-well Costar Multiplates. A 0.5-ml base layer of 0.5% agar (Difco; Noble agar) in Dulbecco's modified Eagle's medium containing 10% fetal calf serum was added per well.
A 0.5-ml overlay of 0.3% agar containing the same medium-fetal serum mixture, 1 x 103 MCF-7cells and the sample to be tested was then added. The cells were incubated at 37°C in a humidified atmosphere of 5%CO2in air. Counting, after 7 days, was restricted to these colonies having more than 20 cells.
Estrogenic Activity of WS-7528 on Immature Rats Groups of 5 Sprague-Dawley rats, only 3 weeks old, were used to ensure absence of endogenous estrogenic activity. NOV. 1990 WS-7528was suspended in a 0.5% solution of methyl cellulose and administered orally or subcutaneously for 3 days, while as a representative example of the conventional drug, 17/?-estradiol was dissolved in the same solution and administered orally or subcutaneously for 3 days. On the 4 th day, each animal was autopsied and its uterine wet weight was recorded.
Inhibition of the Carrageenin Paw Edema
Wister rats, body weight 180~200g were used. WS-7528 was suspended in a 0.5% solution ofmethyl cellulose and administered orally 1 hour before carrageenin injection. The edema was induced by injecting subplantarly 0.1 ml of 1% A-carrageenin solution (made by Sigma) into the right hind paw.
Inflammation was plethysmometrically recorded.
Results
Taxonomic Studies on Strain No. 7528 The vegetative mycelium developed well without fragmentation. The aerial mycelium branched monopodially and formed spiral chains of spores with 20 to 40 spores per chain (Fig. 1) . The spores had a warty surface and were oval in shape with a size of0.6~0.8 x 0.6~0.9 /mi. Sclerotic granules, sporangia and zoospores were not observed. The aerial mycelium was gray to brownish gray. Fig-lå 
Summarized physiological properties of strain
No. 7528 are shown in Table 2 . This strain could utilize many carbon sources tested for growth (Table 3) .
Based on the taxonomic properties described above, strain No. 7528 is considered to belong to the genus Streptomyces and to be a strain of the gray series of the Pridham and Tresner grouping.9* Isolation and Purification The isolation scheme is shown in Fig. 2 . The cultured broth (150 liters) was filtered with the aid of diatomaceous earth (4 kg). To the mycelia containing diatomaceous earth, were added 100 liters of acetone and the mixture was stirred for 30 minutes. The suspension of mycelia was filtered and the filtrate was concentrated in vacuo to a volume of 20 liters. This concentrate was extracted with ethyl acetate at pH 7.0 (20 liters x 2). The ethyl acetate layer was washed with water, dried with anhydrous Na2SO4 and evaporated to give an oily residue. The oily residue was mixed with 300g of silica gel (Kieselgel 60, 70~230 mesh, made by Merck Co., Ltd.), and this mixture was slurried in methanol. After evaporating the solvent, the resultant dry powder was subjected to column chromatography using the same silica gel (1.5 liters, column size: ll x 16cm) which was packed with chloroform. The column was washed with a mixture of chloroform and methanol (50: 1) and eluted with a mixture of chloroform and methanol (20: 1).
The fractions containing the active compoundwere evaporated, dissolved in a mixture of«-hexane and ethyl acetate (4 : 1) and applied to silica gel (Kieselgel 60, 230~400 mesh, 200ml). The column was washed with the same solvent, then developed with a mixture of «-hexane and ethyl acetate (3 : 2). The active fractions were evaporated in vacuo to give a yellow powder. This powder was dissolved in methanol and was treated to HPLC. The column (Cosmosil C18, 10 x 250mm, purchased from Nakarai Chemicals, Ltd.) was developed with 60% aq methanol containing 0.1% acetic acid. The active fractions were collected and concentrated under reduced pressure to a volume of 50ml. This solution was neutralized with 1 n NaCl and extracted with ethyl acetate. The ethyl acetate extract was concentrated to dryness and subsequently obtained as a pale yellow powder (400 mg) after recrystallization from a mixture of^2-hexane and diethyl ether.
Physico-chemical Properties The IR spectrum of WS-7528 is shown in Fig. 3 . 13C NMRspectrum of WS-7528 is shown in Fig.  4 . The Rf value of WS-7528 on silica gel TLC developed with rc-hexane-ethyl acetate (3 : 2) was 0.25. The other physico-chemical properties are summarized in Table 4 . The structure is shown in Fig. 5 . WS-7528 (1) is a weakly acidic, optically active substance. The molecular formula (C16H14O5) of 1 was established by elemental analysis and EI-MS (Table 4 NMRspectrum (CD3OD). The 1 1 protons observed in the *H NMR spectrum of 1 were assignable to those of 4-substituted phenol, 5,6-disubstituted resorcinol, tetrasubstituted ethylene, and methyl groups as shown in Table 5 . The UV spectrum To a solution of WS-7528 (100mg) in pyridine (2ml) was added AC2O(1 ml) and the mixture was allowed to stand overnight at roomtemperature. The reaction mixture was evaporated to dryness under reduced pressure. The residue was taken in CH2C12, washed with H2O, dried over MgSO4, and evaporated to give a residue, which was purified by preparative TLC (CHC13-MeOH,50 : 1) to give triacetate (60mg):
oily. The IC50 values of compounds we tested are summarized in Table 6 . Whenincluded in the growth medium for the cell line MCF-7, this compound was capable of inducing cell growth (Table 7) . This effect was dose dependent, at lO^g/ml the growth observed was twice that of control. Estrogenic activities of WS-7528 on immature rats are shown in Tables 8 and 9 . WS-7528 at the daily dose levels of 3.3mg/kg, lOmg/kg (orally), and 2.5mg/kg (subcutaneously) resulted in uterine weight increasing effect with a dose-response curve of moderate gradient. Weak anti-inflammatory activity by WS-7528 was observed. An injection of lOOmg/kg of the compound reduced an induced inflammation by 23%. Antimicrobial activities of WS-7528 was evaluated by a serial broth dilution method. WS-7528 was not effective against somestrains wetested.
EI-MS (M+H
Acute toxicity of WS-7528 was examined in ddY mice (female, 5 weeks old) by a single intraperitoneal or subcutaneously injection of graded doses of the compound into five mice. The LD50value of WS-7528 was above 500mg/kg.
Discussion
Wehave routinely examined compounds of microbial origin for estrogen receptor binding activity. As a result of our screening program, the highly potent estrogen receptor binding compound WS-7528 has been isolated. 11>12) In vivo studies using immaturefemale rats and in vitro studies using the estrogen dependent cell line MCF-7show that WS-7528has agonistic activity. A potential use of estrogen agonist is in the treatment ofosteoporosis. Osteoporosis is an almost universal phenomenonin aging people, especially postmenopausal women, and poses a great risk to those suffering from the disorder.
Estrogens are knownto be capable of preventing osteoporosis, however, they also have undesirable effects on other body functions, thus limiting their use in treatment.
The developmentof milder estrogenic substances with no side effects remains a possible strategy to combat osteoporosis. In this regard, this preliminary study suggests that WS-7528may be a possible candidate for further development. Detailed studies on WS-7528and other compoundsare currently ongoing in our laboratory.
After preparation of this paper, we noticed that Banyu-group intend to report a compound BE-14348-B which is identical with WS-7528.
